We are live on ! Find out more
AJOVista

AJOVista Portfolio holdings

AUM $23.4M Turnover 93.14%
1-Year Est. Return 76.18%
This Fund
S&P 500
This Quarter Est. Return
+29.83%
1 Year Est. Return
+76.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$23.4M
AUM Growth
-$11.3M
Cap. Flow
-$13.9M
Cap. Flow %
-59.37%
Top 10 Hldgs %
39.09%
Holding
175
New
100
Increased
8
Reduced
3
Closed
63
Avg Time Held
0.1 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.1 years

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$1.56M
2
QFIN icon
Qfin Holdings
QFIN
+$1.24M
3
JD icon
JD.com
JD
+$852K
4
BABA icon
Alibaba
BABA
+$723K
5
VALE icon
Vale
VALE
+$325K

Top Sells

Rank Stock Value
1
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$6.05M
2
AAPL icon
Apple
AAPL
+$2.32M
3
NVDA icon
NVIDIA
NVDA
+$2.3M
4
MSFT icon
Microsoft
MSFT
+$2.19M
5
AMZN icon
Amazon
AMZN
+$1.36M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.05%
2 Healthcare 18.66%
3 Financials 12.06%
4 Industrials 9.93%
5 Materials 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
OCUL icon
76
Ocular Therapeutix
OCUL
$1.31B
$96.8K 0.41%
+11,123
New +$91.7K
2024 Q3
0 quarters
TSVT icon
77
DELISTED
2seventy bio
TSVT
$95.6K 0.41%
+20,255
New +$91.3K
2024 Q3
0 quarters
VISN icon
78
Vistance Networks
VISN
$839M
$92.6K 0.4%
+15,158
New +$52K
2024 Q3
0 quarters
MFIN icon
79
Medallion Financial
MFIN
$217M
$88.3K 0.38%
10,849
– –
2024 Q2
1 quarter
ABAT icon
80
American Battery Technology
ABAT
$129M
$84.9K 0.36%
+79,305
New +$82.5K
2024 Q3
0 quarters
RMTI icon
81
Rockwell Medical
RMTI
$24.2M
$83.8K 0.36%
+2,110
New +$56.8K
2024 Q3
0 quarters
GRNT icon
82
Granite Ridge Resources
GRNT
$756M
$81.4K 0.35%
+13,711
New +$87.8K
2024 Q3
0 quarters
BDSX icon
83
Biodesix
BDSX
$93.1M
$80.3K 0.34%
+2,256
New +$77.6K
2024 Q3
0 quarters
SLDP icon
84
Solid Power
SLDP
$353M
$78.3K 0.33%
+58,023
New +$91.8K
2024 Q3
0 quarters
UIS icon
85
Unisys
UIS
$189M
$77.6K 0.33%
13,658
+3,097
+29% +$15.3K
2023 Q4
3 quarters
NXDR icon
86
Nextdoor Holdings
NXDR
$774M
$77.1K 0.33%
+31,085
New +$79.9K
2024 Q3
0 quarters
SRTA icon
87
Strata Critical Medical
SRTA
$443M
$69K 0.29%
+23,474
New +$74.7K
2024 Q3
0 quarters
MDXG icon
88
MiMedx Group
MDXG
$464M
$68.3K 0.29%
+11,561
New +$76.6K
2024 Q3
0 quarters
SVRA icon
89
Savara
SVRA
$1.04B
$66.2K 0.28%
15,611
+2,545
+19% +$11.2K
2023 Q4
3 quarters
FULC icon
90
Fulcrum Therapeutics
FULC
$284M
$65.5K 0.28%
+18,349
New +$136K
2024 Q3
0 quarters
ASRT icon
91
DELISTED
Assertio
ASRT
$64.1K 0.27%
+3,624
New +$71.8K
2024 Q3
0 quarters
NAGE icon
92
Niagen Bioscience
NAGE
$154M
$64.1K 0.27%
17,552
+7,440
+74% +$23.4K
2024 Q2
1 quarter
ORGO icon
93
Organogenesis Holdings
ORGO
$111M
$61.7K 0.26%
21,568
+6,055
+39% +$17K
2024 Q2
1 quarter
BRY icon
94
DELISTED
Berry Corp
BRY
$60.6K 0.26%
+11,787
New +$72K
2024 Q3
0 quarters
ALEC icon
95
Alector
ALEC
$383M
$56.5K 0.24%
+12,117
New +$65K
2024 Q3
0 quarters
DSGN icon
96
Design Therapeutics
DSGN
$606M
$55.5K 0.24%
+10,319
New +$48.5K
2024 Q3
0 quarters
VNDA icon
97
Vanda Pharmaceuticals
VNDA
$227M
$54.2K 0.23%
+11,552
New +$61.9K
2024 Q3
0 quarters
PRCH icon
98
Porch Group
PRCH
$2.37B
$49K 0.21%
31,892
-12,363
-28% -$19.4K
2023 Q4
3 quarters
BLND icon
99
Blend Labs
BLND
$219M
$46.7K 0.2%
+12,447
New +$41.3K
2024 Q3
0 quarters
BTE icon
100
Baytex Energy
BTE
$2.66B
$46.3K 0.2%
+15,576
New +$53K
2024 Q3
0 quarters

Similar funds

AJOVista's Q3 2024 Portfolio in Review

As of Q3 2024, AJOVista held 175 positions worth $23.4M, down 33% from $34.7M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

AJOVista withdrew a net $13.9M in Q3 2024, closing 63 positions and reducing 3 holdings. Its most notable exit was Apple, an estimated $2.32M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 9.4% a quarter earlier, followed by Healthcare and Financials.

Against the trend, AJOVista opened a new position in KE Holdings worth $2.1M.

  • AJOVista's largest Q3 2024 buy was KE Holdings: 105,472 shares worth $2.1M.
  • AJOVista added most to Eagle Pharmaceuticals in Q3 2024, an estimated $216K increase.
  • AJOVista's biggest Q3 2024 reduction was iShares MSCI Saudi Arabia ETF, cutting an estimated $6.05M.
  • AJOVista fully exited Apple in Q3 2024, selling an estimated $2.32M.
  • AJOVista's ten largest holdings make up 39% of its $23.4M portfolio in Q3 2024.
  • AJOVista opened 100 new positions and closed 63 in Q3 2024.
  • AJOVista's portfolio value fell 33% quarter-over-quarter to $23.4M.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.